Key Dates

Related Announcements

PAR-22-054 - Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this Notice is to inform potential applicants of a change to Review dates for Funding Opportunity Announcement (FOA) PAR-22-054, “Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)"

The following modifications have been made to PAR-22-054:

Currently Reads:

Part 1. Overview

Key Dates

Review and Award Cycles

Scientific Merit Review

July 2022

Advisory Council Review

October 2022

Earliest Start Date

December 2022

Modified to Read (changes shown in bold italics):

Part 1. Overview

Key Dates

Review and Award Cycles

Scientific Merit Review

April/May 2022

Advisory Council Review

Not Applicable

Earliest Start Date

July 2022

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

James Coulombe, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Email: [email protected]

Huiqing Li, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]

Lu Wang, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Email: [email protected]

Malcolm A. Smith, M.D., Ph.D.
National Cancer Institute (NCI)
Email: [email protected]

Jaime M. Guidry Auvil, Ph.D.
National Cancer Institute (NCI)
Email: [email protected]